Wiener Klinische Wochenschrift

, 115:676

Complementary therapies for cancer, more good than harm?



  1. 1.
    Spiegel W, Zidek T, Vutuc C, Maier M, Isak K, Micksche M (2003) Complementary therapies is cancer patients: prevalence and patients’ motives. Wien Klin Wochenschr 115: 705–709PubMedCrossRefGoogle Scholar
  2. 2.
    Ernst E, Cassileth BR (1998) The prevalence of complementary/alternative medicine in cancer. Cancer 83: 777–782PubMedCrossRefGoogle Scholar
  3. 3.
    Ponholzer A, Struhal G, Madersbacher S (2003) Frequent use of complementary medicine by prostate cancer patients. Eur Urol 43: 604–608PubMedGoogle Scholar
  4. 4.
    Hyodo I, Eguchi K, Nishina T, Endo H, Tanimizu M, Mikami I, Takashima S, Imanishi J (2003) Perceptions and attitudes of clinical oncologists on complementary and alternative medicine. A nation wide survey in Japan. Cancer 97: 2861–2868PubMedCrossRefGoogle Scholar
  5. 5.
    Ernst E, Pittler MH, Stevinson C, White AR (2001) The desktop guide to complementary and alternative medicine. Mosby, EdinburghGoogle Scholar
  6. 6.
    Lewis CR, de Vedia A, Reuer B, Schwan R, Tourin C (2003) Integrating complementary and alternative medicine (CAM) into standard hospice and palliative care. Am J Hospice Pall Care 20: 221–228CrossRefGoogle Scholar
  7. 7.
    Ernst E (2002) “Alternative” medicine and science — like fire and water? Wien Klin Wochenschr 114: 655–656PubMedGoogle Scholar
  8. 8.
    Wilkinson S, Gomella LG, Smith JA, Brawer MK, Dawson NA, Wajsman Z, Dai L, Chodak GW (2002) Attitudes and use of complementary medicine in men with prostate cancer. J Urology 168: 2505–2509CrossRefGoogle Scholar
  9. 9.
    Ryu SD, Chung WG (2003) Induction of the procarcinogen-activating CYPIA2 by a herbal dietary supplement in rats and humans. Food Chemical Toxicology 41: 861–866CrossRefGoogle Scholar
  10. 10.
    Wilkinson S, Chodak GW (2003) Critical review of complementary therapies for prostate cancer. J Clin Oncology 21: 2199–2110CrossRefGoogle Scholar
  11. 11.
    Hiller B (2003) Was Krebspatienten wissen wollen — alternative Krebstherapie seit 1991. Deutsches Ärzteblatt 100: A1182-A1185Google Scholar
  12. 12.
    Ernst E, Schmidt K, Steuer-Vogt MK. Mistletoe for cancer? A systematic review of randomised clinical trials Int J Cancer (accepted for publication)Google Scholar
  13. 13.
    Chrystal K, Allan S, Forgeson G, Isaacs R (2003) The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre. NZ Med J 116: 1–8Google Scholar
  14. 14.
    Risberg T, Vickers A, Bremnes RM, Wist EA, Kaasa S, Cassileth BR (2003) Does use of alternative medicine predict survival from cancer? Eur J Cancer 39: 372–377PubMedCrossRefGoogle Scholar
  15. 15.
    Burstein HJ, Gleber S, Guadagnoli E, Weeks JC (1999) Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 340: 1733–1739PubMedCrossRefGoogle Scholar
  16. 16.
    Ernst E, Schmidt K (2002) ‘Alternative’ cancer cures via the Internet? Br J Cancer 87: 479–480PubMedCrossRefGoogle Scholar
  17. 17.
    Ernst E (2002) “Flower remedies”: A systematic review of clinical evidence. Wien Klin Wochenschr 114: 963–966PubMedGoogle Scholar
  18. 18.
    Ernst E (2003) Ethics and complementary and alternative medicine. Ann Intern Med 138: 940PubMedGoogle Scholar

Copyright information

© Springer 2003

Authors and Affiliations

  1. 1.Complementary Medicine, Peninsula Medical SchoolUniversities of Plymouth & ExeterExeterU.K.

Personalised recommendations